BioCardia, Inc. financial data

Symbol
BCDA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
320 Soquel Way, Sunnyvale, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Tiger X Medical, Inc. (to 10/17/2016), Cardo Medical, Inc. (to 5/25/2011), CLICKNSETTLE COM INC (to 10/20/2008), NAM CORP (to 3/29/2000)
Latest financial report
10-K - Q4 2024 - Mar 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 79 % -14.9%
Debt-to-equity -2.51K % -268%
Return On Equity 4.92K %
Return On Assets -204 % +10.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.68M shares -82.5%
Common Stock, Shares, Outstanding 4.6M shares +192%
Entity Public Float 5.6M USD -88.3%
Common Stock, Value, Issued 5K USD +150%
Weighted Average Number of Shares Outstanding, Basic 2.74M shares +94.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 4.39M USD -43.2%
Costs and Expenses 8.06M USD -33.5%
Operating Income (Loss) -8M USD +31.3%
Nonoperating Income (Expense) 55K USD -24.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -7.95M USD +31.3%
Earnings Per Share, Basic -2.9 USD/shares +64.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.37M USD +115%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 2.62M USD +79.5%
Property, Plant and Equipment, Net 33K USD -64.9%
Operating Lease, Right-of-Use Asset 898K USD -28.8%
Other Assets, Noncurrent 171K USD 0%
Assets 3.72M USD +24.7%
Accounts Payable, Current 385K USD -56.7%
Accrued Liabilities, Current 22K USD -70.7%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 2.32M USD -35.7%
Operating Lease, Liability, Noncurrent 566K USD -42.4%
Liabilities 2.89M USD -37.1%
Retained Earnings (Accumulated Deficit) -160M USD -5.22%
Stockholders' Equity Attributable to Parent 837K USD
Liabilities and Equity 3.72M USD +24.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.53M USD +40.2%
Net Cash Provided by (Used in) Financing Activities 1.38M USD +2050%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 50M shares -50%
Common Stock, Shares, Issued 4.52M shares -79.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -154K USD +93.9%
Deferred Tax Assets, Valuation Allowance 38.5M USD +4.86%
Deferred Tax Assets, Gross 38.5M USD +4.86%
Operating Lease, Liability 951K USD -27.7%
Depreciation 67K USD -20.2%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1.06M USD -31.5%
Property, Plant and Equipment, Gross 794K USD +0.76%
Operating Lease, Liability, Current 385K USD +15.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 514K USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 499K USD +2.89%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 106K USD -53.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 44K USD -91.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 1.78M USD +5.84%
Lessee, Operating Lease, Liability, to be Paid, Year Four 44K USD -91.4%
Operating Lease, Payments 365K USD +15.9%
Additional Paid in Capital 161M USD +6.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 19K USD -13.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 741K USD -28.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%